"10.1371_journal.pone.0091039","plos one","2014-03-10T00:00:00Z","Moon Hee Jeong; Nguyen Khoi Song Tran; Tae Hwan Kwak; Byung Keon Park; Chul Soon Lee; Tae-Sik Park; Young-Hoon Lee; Woo Jin Park; Dong Kwon Yang","College of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea; Department of Life Science, Gachon University, Sungnam, Korea; R&D Center, KT&G Life Sciences Corp., Suwon, Korea; Department of Oral Anatomy, School of Dentistry and Institute of Oral Biosciences, Chonbuk National University, Jeonju, Korea","Conceived and designed the experiments: MHJ WJP DKY. Performed the experiments: MHJ NKT BKP CSL TSP YHL. Analyzed the data: MHJ NKT CSL TSP YHL. Contributed reagents/materials/analysis tools: THK CSL TSP YHL. Wrote the paper: MHJ WJP DKY.","Tae Hwan Kawk is an employee of R&D center, KT&G Life Sciences Corp. and has a patent which protects the use of Î²-lapachone for the treatment of metabolic diseases. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. -lapachones patent information: WO 2009084834 A2, A3; PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE EP 2231148 A4; PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE US 2011-0002995 A1; PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE.","2014","03","Moon Hee Jeong","MHJ",9,TRUE,3,6,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
